Overview
Male infertility due to large-headed multiflagellar polyploid spermatozoa (also known as macrozoospermia) is a rare genetic condition affecting male reproductive function. It is characterized by the presence of abnormal sperm cells that have enlarged heads (macrocephalic), multiple flagella (tails), and an abnormal number of chromosomes (polyploidy). The condition is a specific form of teratozoospermia, meaning the sperm have abnormal morphology. Affected men are typically identified during fertility evaluations, as the condition leads to primary male infertility. The abnormal sperm are unable to successfully fertilize an egg naturally due to their structural and chromosomal abnormalities. The most commonly identified genetic cause of this condition is homozygous mutations in the AURKC gene (Aurora Kinase C), located on chromosome 19q13.43. Aurora Kinase C plays a critical role in meiosis, the cell division process that produces sperm cells. When this gene is dysfunctional, meiotic division fails to complete properly, resulting in spermatozoa that are diploid or polyploid rather than haploid, with correspondingly enlarged heads and multiple tails. The condition has been particularly reported in North African populations, where a specific founder mutation (c.144delC) in AURKC has been identified at a relatively higher carrier frequency. Currently, there is no curative treatment for this condition. Natural conception is not possible due to the severe sperm abnormalities. Conventional assisted reproductive technologies such as intracytoplasmic sperm injection (ICSI) have generally shown poor outcomes because the injected sperm carry an abnormal chromosomal complement, leading to failed fertilization, abnormal embryo development, or early pregnancy loss. Genetic counseling is recommended for affected individuals and their families. Donor sperm insemination remains an alternative option for couples seeking to have children. Research into improved selection techniques for rare normal sperm within the ejaculate is ongoing but remains experimental.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Male infertility due to large-headed multiflagellar polyploid spermatozoa.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Male infertility due to large-headed multiflagellar polyploid spermatozoa at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Male infertility due to large-headed multiflagellar polyploid spermatozoa.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Male infertility due to large-headed multiflagellar polyploid spermatozoa.
Community
No community posts yet. Be the first to share your experience with Male infertility due to large-headed multiflagellar polyploid spermatozoa.
Start the conversation →Latest news about Male infertility due to large-headed multiflagellar polyploid spermatozoa
No recent news articles for Male infertility due to large-headed multiflagellar polyploid spermatozoa.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Male infertility due to large-headed multiflagellar polyploid spermatozoa
What is Male infertility due to large-headed multiflagellar polyploid spermatozoa?
Male infertility due to large-headed multiflagellar polyploid spermatozoa (also known as macrozoospermia) is a rare genetic condition affecting male reproductive function. It is characterized by the presence of abnormal sperm cells that have enlarged heads (macrocephalic), multiple flagella (tails), and an abnormal number of chromosomes (polyploidy). The condition is a specific form of teratozoospermia, meaning the sperm have abnormal morphology. Affected men are typically identified during fertility evaluations, as the condition leads to primary male infertility. The abnormal sperm are unable
How is Male infertility due to large-headed multiflagellar polyploid spermatozoa inherited?
Male infertility due to large-headed multiflagellar polyploid spermatozoa follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Male infertility due to large-headed multiflagellar polyploid spermatozoa typically begin?
Typical onset of Male infertility due to large-headed multiflagellar polyploid spermatozoa is adult. Age of onset can vary across affected individuals.